LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Pfizer Inc. (PFE) (“Pfizer” or the “Company”) (NYSE: PFE) investors concerning the Company’s possible violations of the federal securities laws.
If you suffered a loss on your Pfizer investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/pfizer-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
On October 26, 2022, Bloomberg reported that Pfizer is the target of an Italian probe claiming that the Company hid at least 1.2 billion euros in profit by transferring money to units in other countries, including the US and the Netherlands to avoid taxes on profits. The probe began in February and covers 2017 through 2019.
Whistleblower Notice: Persons with non-public information regarding Pfizer should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email...
Welcome to Reality Check, NewsGuard’s nonpartisan newsletter that tracks the false claims and conspiracy theories that shape our world — and who’s behind them. A note to readers: We just scored a b...